Literature DB >> 33704606

ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response.

Rita A Mukhtar1, Judy C Boughey2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33704606     DOI： 10.1245/s10434-021-09730-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.

Authors:  Nina Tamirisa; Hannah V Williamson; Samantha M Thomas; Kelly E Westbrook; Rachel A Greenup; Jennifer K Plichta; Laura H Rosenberger; Terry Hyslop; Eun-Sil Shelley Hwang; Oluwadamilola M Fayanju
Journal:  J Surg Oncol       Date:  2019-05-06       Impact factor: 3.454

2.  Clinical and pathological stage discordance among 433,514 breast cancer patients.

Authors:  Jennifer K Plichta; Samantha M Thomas; Amanda R Sergesketter; Rachel A Greenup; Oluwadamilola M Fayanju; Laura H Rosenberger; Nina Tamirisa; Terry Hyslop; E Shelley Hwang
Journal:  Am J Surg       Date:  2019-07-18       Impact factor: 2.565

3.  Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma.

Authors:  M J Thornton; H V Williamson; K E Westbrook; R A Greenup; J K Plichta; L H Rosenberger; A M Gupta; T Hyslop; E S Hwang; O M Fayanju
Journal:  Ann Surg Oncol       Date:  2019-07-24       Impact factor: 5.344
  3 in total
  1 in total

1.  Specific Histological Subgroups in Invasive Lobular Carcinoma Might Affect Management Strategy in Invasive Lobular Carcinoma of the Breast.

Authors:  Kadri Altundag
Journal:  Ann Surg Oncol       Date:  2021-05-13       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.